Current stage?-Stage III - Page 33 of 33 Posts on Medivizor
Navigation Menu

Current stage?-Stage III Posts on Medivizor

Sexual, urinary, hormonal and bowel function – a comparison between prostate cancer survivors and noncancer men

Sexual, urinary, hormonal and bowel function – a comparison between prostate cancer survivors and noncancer men

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell The present study compared survivors of prostate cancer (PC) to patients of similar sexes and ages that have not had prostate cancer (non-cancer controls) based on the effects of prior treatments and treatment options on sexual, urinary, bowel and hormone functions. The main finding was that PC survivors had poorer sexual and urinary...

Read More

Radiation therapy for prostate cancer: how long do urinary-related side effects last?

Radiation therapy for prostate cancer: how long do urinary-related side effects last?

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell The present study examined the duration of urinary-related side effects resulting from radiation therapy. Mild to severe urinary side effects were found to last up to 10 years post radiation therapy. Some background Prostate cancer is a slow growing form of cancer that is often managed by active surveillance or observation (delayed...

Read More

New drugs for advanced prostate cancer

New drugs for advanced prostate cancer

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

The aim of this article was to describe some of the most interesting developments concerning new therapies for advanced prostate cancer. During the last years new experimental therapeutic agents for the treatment of advanced prostate cancer have been developed. These are based on the recent discoveries on prostate cell function, resistance to...

Read More

Preserving Fertility during Cancer Treatment

Preserving Fertility during Cancer Treatment

Posted by on Feb 24, 2013 in Breast cancer | 0 comments

In a nutshell This paper reviews available options for having children after cancer treatment. The main conclusion is that sperm, egg and embryo preservation techniques can help young women have children after breast cancer treatment.  Alternative options, such as ovarian tissue preservation, are also being developed. Some background...

Read More

Experimental drug – Enzalutamide – moderately increases survival in patients with advanced prostate cancer

Experimental drug – Enzalutamide – moderately increases survival in patients with advanced prostate cancer

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell This clinical trial evaluated the survival benefits of a drug named Enzalutamide (Xtandi) for patients with non-responsive (refractory) advanced prostate cancer previously treated with chemotherapy. Main findings: Enzalutamide prolonged survival by approximately 5 months and reduced the risk of death by 37%. Some background The...

Read More

Standard Chemotherapy versus Capecitabine (Xeloda) in Older Women with Early-Stage Breast Cancer

Standard Chemotherapy versus Capecitabine (Xeloda) in Older Women with Early-Stage Breast Cancer

Posted by on Feb 24, 2013 in Breast cancer | 0 comments

In a nutshell This trial compared standard chemotherapy regimens and Capecitabine (Xeloda) in women over 65 years old. The main outcome was that standard chemotherapy worked better in this age group. Some background Capecitabine is generally used in breast cancer resistant to other chemotherapy. It is also the first approved treatment that can be...

Read More